Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
113.2 USD | +3.23% | +3.02% | -7.99% |
07:10pm | US reclassification could drive fresh research funding into pot sector | RE |
May. 07 | Jazz Pharmaceuticals Insider Sold Shares Worth $548,250, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.99% | 6.91B | |
+29.98% | 684B | |
+30.34% | 568B | |
-3.52% | 361B | |
+18.59% | 329B | |
+4.07% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.09% | 166B |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- Needham Adjusts Price Target on Jazz Pharmaceuticals to $205 From $210, Maintains Buy Rating